Immunogenicity and shedding of live-attenuated intranasal respiratory syncytial virus vaccine in children aged 6–18 months by baseline serostatus: a multicentre, randomised, placebo-controlled, phase 1/2 trial

The Lancet Microbe · Elsevier

Аннотация

Publication date: Available online 13 October 2026 Source: The Lancet Microbe Author(s): Olubukola T Idoko, Sergio L Vargas, Agustin Bueso, Doris Rivera, Henderson Edward, Peyman Banooni, Shaun Berger, Stephane Janicot, Camille Vercasson, Sophie Pallardy, Rapi Nteene, Haritha Adhikarla, Eric Gerchman, Monica Gasparotto, Scott Gallichan, Enrique Rivas, Ursula J Buchholz, Sanie Sesay, Sanjay Gurunathan, Iris De Bruijn

Читать у издателя →

Похожие статьи